Search Results

There are 24370 results for: content related to: A randomized phase II trial of adjuvant chemotherapy with uracil/tegafur and gemcitabine versus gemcitabine alone in patients with resected pancreatic cancer

  1. You have free access to this content
    Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma

    Cancer

    Volume 116, Issue 22, 15 November 2010, Pages: 5200–5206, Raphaël Maréchal, John R. Mackey, Raymond Lai, Pieter Demetter, Marc Peeters, Marc Polus, Carol E. Cass, Isabelle Salmon, Jacques Devière and Jean-Luc Van Laethem

    Article first published online : 3 NOV 2010, DOI: 10.1002/cncr.25303

  2. Intravesical gemcitabine for non-muscle invasive bladder cancer

    Intervention Review

    The Cochrane Library

    Gabriel Jones, Anne Cleves, Timothy J Wilt, Malcolm Mason, Howard G Kynaston and Mike Shelley

    Published Online : 18 JAN 2012, DOI: 10.1002/14651858.CD009294.pub2

  3. You have free access to this content
    Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review

    BJU International

    Volume 109, Issue 4, February 2012, Pages: 496–505, Mike D. Shelley, Gabriel Jones, Anne Cleves, Timothy J. Wilt, Malcolm D. Mason and Howard G. Kynaston

    Article first published online : 7 FEB 2012, DOI: 10.1111/j.1464-410X.2011.10880.x

  4. Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma

    Journal of Surgical Oncology

    Volume 106, Issue 2, 1 August 2012, Pages: 174–180, Yoshiaki Murakami, Kenichiro Uemura, Takeshi Sudo, Yasushi Hashimoto, Akira Nakashima, Naru Kondo, Naoya Nakagawa and Taijiro Sueda

    Article first published online : 13 FEB 2012, DOI: 10.1002/jso.23068

  5. Survival outcomes in patients with early stage, resected pancreatic cancer – a comparison of gemcitabine- and 5-fluorouracil-based chemotherapy and chemoradiation regimens

    International Journal of Clinical Practice

    Volume 68, Issue 5, May 2014, Pages: 578–589, S. H. Kizilbash, K. C. Ward, J. J. Liang, I. Jaiyesimi and J. Lipscomb

    Article first published online : 29 JAN 2014, DOI: 10.1111/ijcp.12353

  6. A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in a resected pancreaticobiliary carcinoma

    HPB

    May Cho, Andrea Wang-Gillam, Robert Myerson, Feng Gao, Steven Strasberg, Joel Picus, Steven Sorscher, Chloe Fournier, Gayathri Nagaraj, Parag Parikh, Rama Suresh, David Linehan and Benjamin R. Tan

    Article first published online : 20 MAR 2015, DOI: 10.1111/hpb.12413

  7. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer

    Intervention Review

    The Cochrane Library

    Mike Shelley, Anne Cleves, Timothy J Wilt and Malcolm Mason

    Published Online : 13 APR 2011, DOI: 10.1002/14651858.CD008976.pub2

  8. You have full text access to this OnlineOpen article
    Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 2, February 2015, Pages: 340–350, Yang Guo, Andreas Ziesch, Sandra Hocke, Eric Kampmann, Stephanie Ochs, Enrico N. De Toni, Burkhard Göke and Eike Gallmeier

    Article first published online : 21 OCT 2014, DOI: 10.1111/jcmm.12444

  9. Adjuvant therapy for pancreas adenocarcinoma

    Journal of Surgical Oncology

    Volume 107, Issue 1, 1 January 2013, Pages: 78–85, Eileen M. O'Reilly

    Article first published online : 6 AUG 2012, DOI: 10.1002/jso.23230

  10. Primary Pancreatic Adenocarcinoma

    Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

    Christopher L. Wolfgang, Timothy M. Pawlik, Ralph H. Hruban, Karen M. Horton, Elliot K. Fishman, Robert A. Meguid, Daniel Laheru, Joseph Herman, Manuel Hildago, Jeffrey Infante, Wells Messersmith, Pages: 498–542, 2009

    Published Online : 14 JAN 2009, DOI: 10.1002/9781444300147.ch21

  11. Synthesis and characterization of saccharide-functionalized polymer–gemcitabine conjugates based on chemoenzymatic selective strategy

    Journal of Applied Polymer Science

    Volume 124, Issue 3, 5 May 2012, Pages: 1840–1847, Guo-Jun Zhou, Xia Li, Ming-Xing Teng, Guo-Hai Chu and Xian-Fu Lin

    Article first published online : 21 OCT 2011, DOI: 10.1002/app.35201

  12. You have free access to this content
    Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells

    FEBS Journal

    Volume 279, Issue 7, April 2012, Pages: 1261–1273, Fu Li, Gang Hu, Zhenzhou Jiang, Jingjing Guo, Ke Wang, Kedong Ouyang, Danyi Wen, Minghua Zhu, Jiaxin Liang, Xiaoran Qin and Luyong Zhang

    Article first published online : 12 MAR 2012, DOI: 10.1111/j.1742-4658.2012.08521.x

  13. Labeling, biodistribution and evaluation of [125I] gemcitabine: a potential agent for tumor diagnosis and radiotherapy

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 52, Issue 3, March 2009, Pages: 91–97, O. A. El-Kawy, A. M. Hashem, M. A. Amin and A. S. El-Wetery

    Article first published online : 16 JAN 2009, DOI: 10.1002/jlcr.1573

  14. You have free access to this content
    Synthesis and Biological Evaluation of Oral Prodrugs Based on the Structure of Gemcitabine

    Chemical Biology & Drug Design

    Volume 80, Issue 3, September 2012, Pages: 479–488, Cuirong Zhao, Xiaoxia Xue, Gang Li, Cuicui Sun, Changjun Sun, Xianjun Qu and Wenbao Li

    Article first published online : 25 JUN 2012, DOI: 10.1111/j.1747-0285.2012.01422.x

  15. Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue 2, March/April 2006, Pages: 507–514, C.J. POOLE, T. PERREN, S. GAWANDE, M. RIDDERHEIM, J. COOK, A. JENKINS and D. ROYCHOWDHURY

    Article first published online : 25 APR 2006, DOI: 10.1111/j.1525-1438.2006.00466.x

  16. You have full text access to this OnlineOpen article
    Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer

    Cancer Medicine

    Neelam V. Desai, Sarunas Sliesoraitis, Steven J. Hughes, Jose G. Trevino, Robert A. Zlotecki, Alison M. Ivey and Thomas J George Jr

    Article first published online : 13 MAR 2015, DOI: 10.1002/cam4.444

  17. You have free access to this content
    Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors

    Cancer

    Volume 107, Issue 10, 15 November 2006, Pages: 2482–2489, David P. Ryan, Leonard J. Appleman, Thomas Lynch, Jeffrey G. Supko, Panagiotis Fidias, Jeffrey W. Clark, Mayer Fishman, Andrew X. Zhu, Peter C. Enzinger, Oscar Kashala, James Cusack Jr. and Joseph P. Eder

    Article first published online : 11 OCT 2006, DOI: 10.1002/cncr.22264

  18. You have free access to this content
    Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinoma

    Journal of Hepato-Biliary-Pancreatic Sciences

    Volume 18, Issue 5, September 2011, Pages: 700–711, Jun Sato, Takashi Kimura, Takuro Saito, Takayuki Anazawa, Akira Kenjo, Yoshihiro Sato, Takao Tsuchiya and Mitsukazu Gotoh

    Article first published online : 31 MAR 2011, DOI: 10.1007/s00534-011-0376-7

  19. You have free access to this content
    Predictive and prognostic roles of ribonucleotide reductase M1 in resectable pancreatic adenocarcinoma

    Cancer

    Volume 119, Issue 1, 1 January 2013, Pages: 173–181, Hao Xie, Wei Jiang, John Jiang, Yixin Wang, Richard Kim, Xiaobo Liu and Xiuli Liu

    Article first published online : 26 JUN 2012, DOI: 10.1002/cncr.27715

  20. Ceramide metabolism determines glioma cell resistance to chemotherapy

    Journal of Cellular Physiology

    Volume 221, Issue 3, December 2009, Pages: 688–695, Claudia Alexandra Dumitru, Michael Weller and Erich Gulbins

    Article first published online : 26 AUG 2009, DOI: 10.1002/jcp.21907